Keywords: fda, panel, backs, busulfex, approval, food, drug
FDA panel backs Busulfex approval
Article | 21 January 1999
The US Food and Drug Administration's Oncologic Drugs Advisory Committeehas recommended approval of Orphan Medical's Busulfex (injectable busulfan) for use ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
